Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

RenovoRx (RNXT) Gains from Investment Securities (2024 - 2025)

RenovoRx (RNXT) has disclosed Gains from Investment Securities for 2 consecutive years, with -$506000.0 as the latest value for Q4 2025.

Quarterly Gains from Investment Securities fell 252.87% to -$506000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$58000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $117299.0 for FY2025, 95.81% down from the prior year.
Gains from Investment Securities hit -$506000.0 in Q4 2025 for RenovoRx, down from $76019.0 in the prior quarter.
In the past five years, Gains from Investment Securities ranged from a high of $1.3 million in Q2 2024 to a low of -$1.4 million in Q1 2024.